Key result
This is a study protocol for a prospective observational study evaluating wearable devices to monitor physical activity in patients undergoing aortic valve replacement; results are pending.
Why the study?
Tools to measure physical function objectively are not well established in clinical practice, and data comparing physical function changes and feasibility of wearable devices after SAVR versus TAVR are needed.
Observational
Answers are grounded in this paper and cite their sources.
This study protocol describes a prospective observational approach to assess the feasibility of wearable devices for monitoring physical activity and functional changes in patients undergoing aortic valve replacement.
BACKGROUND In last few decades, several tools have been developed to measure physical function objectively; however, their use has not been well established in clinical practice. OBJECTIVE This study aims to describe the preoperative physical function and to assess and compare 6-month postoperative changes in the physical function of patients undergoing treatment for aortic stenosis with either surgical aortic valve replacement (SAVR) or transcatheter aortic valve replacement (TAVR). The study also aims to evaluate the feasibility of wearable devices in assessing physical function in such patients. METHODS This is a prospective observational study. The enrollment will be conducted 1 month before patients’ SAVR/TAVR. Patients will be provided with the wearable device at baseline (activity tracker device, Garmin vívoactive 3). They will be trained in the use of the device, and they will be requested to wear it on the wrist of their preferred hand until 12 months after SAVR/TAVR. After baseline assessment, they will undergo 4 follow-up assessments at 1, 3, 6, and 12 months after SAVR/TAVR. At baseline and each follow-up, they will undergo a set of standard and validated tests to assess physical function, health-related quality of life, and sleep quality. RESULTS The ethics committee of Vicenza in Veneto Region in Italy approved the study (Protocol No. 943; January 4, 2019). As of October 2020, the enrollment of participants is ongoing. CONCLUSIONS The use of the wearable devices for real-time monitoring of physical activity of patients undergoing aortic valve replacement is a promising opportunity for improving the clinical management and consequently, the health outcomes of such patients. CLINICALTRIAL Clinicaltrials.gov NCT03843320; https://tinyurl.com/yyareu5y INTERNATIONAL REGISTERED REPORT DERR1-10.2196/20072
No takes yet. Share an insight, caveat, or question.
Lorenzoni et al. (2020) conducted an observational in Aortic stenosis. Wearable device (Garmin vívoactive 3) was evaluated on 6-month postoperative changes in physical function. This is a study protocol for a prospective observational study evaluating wearable devices to monitor physical activity in patients undergoing aortic valve replacement; results are pending.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: